Artiva Biotherapeutics · 22 hours ago
VP, Clinical Development
United States
Full-time
Remote
Director/Executive
$350K/yr - $385K/yr
15+ years expArtiva Biotherapeutics is a clinical-stage biotechnology company focused on developing NK cell-based therapies for autoimmune diseases and cancers. The Vice President, Clinical Development will provide strategic leadership across Artiva’s pipeline, ensuring regulatory alignment and cross-functional collaboration to advance clinical assets in support of the company’s objectives.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Define and drive the clinical development strategy for assigned programs
Translate scientific, translational, and clinical data into clear development plans, milestone decisions, and risk-benefit assessments
Ensure alignment of clinical strategy with regulatory expectations, target product profiles, and long-term portfolio objectives
Lead the design and oversight and registration-quality clinical trials, including endpoint selection, patient population strategy, and global development considerations
Provide senior clinical oversight to ensure trials meet registration standards for quality, safety, and data integrity
Partner with Biometrics and Regulatory Affairs to ensure clinical strategy supports statistical and regulatory requirements
Provide ongoing medical oversight of clinical trials, including safety monitoring, emerging data review, and protocol amendments
Partner closely with Clinical Operations on trial feasibility, site strategy, enrollment planning, and CRO oversight
Review and interpret clinical data to guide program adjustments and development decisions
Ensure clinical readiness for audits, inspections, and regulatory review
Represent Clinical Development in health authority interactions
Provide clinical leadership for briefing documents, responses to regulatory questions, and clinical components of submissions
Engage with investigators, advisors, and external experts to support development strategy and trial execution
Collaborate closely with Translational Medicine, Safety/Pharmacovigilance, Regulatory Affairs, Biometrics, and CMC teams
Provide clinical input into biomarker strategy, safety strategy, and future lifecycle planning
Qualification
Required
MD required
15+ years of clinical development experience in biotechnology and/or pharmaceutical organizations
Proven leadership of late-stage and registration-enabling clinical trials, including global studies
Direct involvement in regulatory submissions (e.g., NDA, BLA, MAA) and health authority interactions
Experience working in well-established pharmaceutical development environments and applying those practices in smaller or earlier-stage organizations
Background in immunology, autoimmune disease, or cell therapy required
Experience leading programs through key inflection points (e.g., EOP2, pivotal study initiation, registration readiness)
Strong strategic thinking with the ability to integrate clinical, regulatory, and scientific perspectives
Deep understanding of global clinical development and registration pathways
Sound clinical judgment and risk-benefit decision-making capability
Clear and credible communicator with regulators, investigators, executives, and cross-functional teams
Sets a high standard for clinical excellence, patient safety, and data integrity
Operates effectively in ambiguity while driving disciplined execution
Models transparency, collaboration, and patient-centric decision-making
Preferred
Board certification preferred
Benefits
Medical, Dental, and Vision
Group Life Insurance
Long Term Disability (LTD)
401(k) Retirement Plan
Employee Assistance Program (EAP)
Flexible Spending Account (FSA)
Paid Time Off (PTO)
Company paid holidays, including the year-end holiday week
Our recognition program, Bonus.ly, is where you can trade in points earned for things you want.
Company
Artiva Biotherapeutics
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
51-200 employees
Funding
Current Stage
Public CompanyTotal Funding
$198MKey Investors
Venrock Healthcare Capital Partners
2024-07-18IPO
2021-02-26Series B· $120M
2020-06-26Series A· $78M
Leadership Team
Fred Aslan
President and Chief Executive Officer
Neha Krishnamohan
Chief Financial Officer & EVP, Corporate Development
Recent News
2025-12-16
2025-11-15
2025-11-15
Company data provided by crunchbase